InsidersTradesSigma
UCB Stock: price and insider trades · Belgium · FSMA
Track the UCB stock price and the full directors' dealings record of the company, a publicly traded company based in Belgium. Shares are quoted on BE BE, under the supervision of FSMA. Operating in the Healthcare & Pharma sector, UCB has logged 54 public disclosures. Market capitalisation: €48.3bn. The latest transaction was filed on 1 July 2026 (Purchase). Among the most active insiders: Caeymaex Emmanuel. The full history is accessible without an account.
54
Insider Decl.
0
Thresholds
€4m
39 ops.
Buy Volume
€18m
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate UCB Buy (bullish), based on 19 analysts. Average price target: €287.95.
32Σ signal
Fundamental score
Ranked 6,855 of 25,973 companies
63.3
score / 100
Value46
Quality81
FCF yld3.9%
Earn yld3.3%
EV/EBITDA19.3x
ROE15%
Gross mgn74%
Net mgn20%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations54 total
315 shares@ €254.800.0002% mcap100.0% of flowShareEuronext BrusselsFSMA:ucb-214
Ideal exit: 22 Mar 2027 (T+270)
3,084 shares@ €270.890.0019% mcap22.3% of flowShareEuronext BrusselsFSMA:ucb-126
7,937 shares@ €266.700.0047% mcap29.4% of flowShareEuronext BrusselsFSMA:ucb-33
7,937 shares@ €102.040.0018% mcap11.2% of flowShareOff exchangeFSMA:ucb-86
Ideal exit: 3 Jan 2027 (T+270)
1,010 shares@ €271.800.0006% mcap3.8% of flowShareEuronext BrusselsFSMA:ucb-62
4,031 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-129
Ideal exit: 2 Jan 2027 (T+270)
21,643 shares0ShareOff exchangeFSMA:ucb-68
Ideal exit: 27 Dec 2026 (T+270)
780 shares0ShareOff exchangeFSMA:ucb-26
Ideal exit: 27 Dec 2026 (T+270)
3,823 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-46
Ideal exit: 28 Dec 2026 (T+270)
5,802 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-24
Ideal exit: 28 Dec 2026 (T+270)
2,787 shares0ShareOff exchangeFSMA:ucb-131
Ideal exit: 27 Dec 2026 (T+270)
2,787 shares0ShareOff exchangeFSMA:ucb-132
Ideal exit: 27 Dec 2026 (T+270)
2,787 shares0ShareOff exchangeFSMA:ucb-133
Ideal exit: 27 Dec 2026 (T+270)
3,084 shares0ShareOff exchangeFSMA:ucb-225
Ideal exit: 27 Dec 2026 (T+270)
3,528 shares0ShareOff exchangeFSMA:ucb-60
Ideal exit: 27 Dec 2026 (T+270)
11,542 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-116
Ideal exit: 27 Dec 2026 (T+270)
2,549 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-18
Ideal exit: 27 Dec 2026 (T+270)
2,787 shares0ShareOff exchangeFSMA:ucb-178
Ideal exit: 27 Dec 2026 (T+270)
3,873 shares0ShareOff exchangeFSMA:ucb-108
Ideal exit: 27 Dec 2026 (T+270)
4,043 shares0ShareOff exchangeFSMA:ucb-1
Ideal exit: 27 Dec 2026 (T+270)
2,464 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-190
Ideal exit: 28 Dec 2026 (T+270)
3,489 shares0Options /warrants for employees or managersOff exchangeFSMA:ucb-76
Ideal exit: 29 Dec 2026 (T+270)
3,000 shares@ €254.2710.6% of flowShareEuronext BrusselsFSMA:ucb-198
3,000 shares@ €79.993.3% of flowShareOff exchangeFSMA:ucb-187
Ideal exit: 5 Oct 2026 (T+270)
500 shares@ €255.49100.0% of flowShareOff exchangeFSMA:ucb-107
Ideal exit: 4 Oct 2026 (T+270)
25 of 54 declarations
About UCB
UCB is a Belgian biopharmaceutical company focused on developing medicines for severe diseases. It is listed on the Brussels stock market (XBRU).
